Company Overview and News
As shares of General Electric Company (NYSE:GE) have plunged, the calls for a breakup have grown louder. Bulls see the true value of GE stock as clouded by issues at GE Capital and weakness in divisions such as Lighting and Transportation. With two still-growing businesses — Aviation and Healthcare — plus a 62.5% stake in Baker Hughes a GE Co (NYSE:BHGE), optimists argue there has to be some value in General Electric stock, particularly after a 50%-plus decline from 2016 highs.
ERII is a highly valued company that loses money. Their cash losses are even higher than the losses they report.
In its weekly release, Baker Hughes (BHGE - Free Report) , a GE company, reported an increase in rig count in the United States.
A month has gone by since the last earnings report for Schlumberger Limited (SLB - Free Report) . Shares have added about 5.9% in that time frame.
Designed to provide broad exposure to the Energy - Equipment and services segment of the U.S. equity market, the iShares U.S. Oil Equipment & Services ETF (IEZ - Free Report) is a passively managed exchange traded fund launched on 05/01/2006.
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Wednesday, May 16.
Looking for broad exposure to the Energy - Broad segment of the U.S. equity market? You should consider the Fidelity MSCI Energy Index ETF (FENY - Free Report) , a passively managed exchange traded fund launched on 10/21/2013.
Launched on 05/01/2006, the iShares U.S. Oil Equipment & Services ETF (IEZ - Free Report) is a passively managed exchange traded fund designed to provide a broad exposure to the Energy - Equipment and services segment of the U.S. equity market.
The portfolio continues to be heavily concentrated, with the top three positions accounting for one-third of the 13F portfolio.
Form SD UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
The combination of surging output, oil prices at three-year highs and spending under control means that the shale patch -- which has notoriously burnt more cash than it makes as investors bankroll their expansion -- got closer to a milestone in the first-quarter: Positive free cash flow. As oil rises above $70/bbl, the outlook for the coming quarters looks even brighter.
HOUSTON (Reuters) - Venezuela’s state-run oil firm PDVSA [PDVSA.UL] is being sued for more than $25 million in the United States over nonpayment of notes issued for work performed by Canadian energy contractor SNC-Lavalin, according to a court filing.
Since its re-emergence, oil prices have surged, yet Energy XXI Gulf Coast shares have collapsed, creating an asymmetric return opportunity.
2018-05-21 - Asif
Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...
2018-05-21 - Asif
Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...
2018-05-21 - Asif
Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...
as of ET